Home / Recalls / Drug Depot, Inc., dba APS Pharmacy / D-0729-2022

D-0729-2022 Class II Terminated

Recalled by Drug Depot, Inc., dba APS Pharmacy — Palm Harbor, FL

Recall Details

Product Type
Drugs
Report Date
April 6, 2022
Initiation Date
March 23, 2022
Termination Date
October 5, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1843 vials

Product Description

(CA) GONADORELIN (4ML) 0.2 MG/ML INJECTABLE, Packaged in a multi dose 10ML vial, Formula ID136345, APS Pharmacy

Reason for Recall

Lack of sterility assurance.

Distribution Pattern

Nationwide in the USA including Puerto Rico.

Code Information

Lots: 749842 BUD: 7/13/2022; 749568 BUD: 7/12/2022; 752053 BUD: 7/23/2022; 752817 BUD: 7/25/2022; 757404 BUD: 8/21/2022; 757915 BUD: 8/23/2022; 757321 BUD: 8/20/2022; 753718 BUD: 7/30/2022

Other recalls by Drug Depot, Inc., dba APS Pharmacy

  • D-0731-2022 Class II — TESTOSTERONE CYPIONATE/ ANASTROZOLE *GS* OIL (10ML) 200MG/0.5MG/ML; Packaged in (March 23, 2022)
  • D-0732-2022 Class II — TESTOSTERONE CYPIONATE/ DHEA *GS* 200/10MG/ML Injectable, Packaged in a multi do (March 23, 2022)
  • D-0733-2022 Class II — TESTOSTERONE CYPIONATE/PROPIONATE *SES* Oil (10 ML) 160MG/20MG/ML Injectable, Pa (March 23, 2022)
  • D-0730-2022 Class II — TESTOSTERONE CYPIONATE/ANASTROZOLE *GS* OIL 200MG/1MG/ML Injectable, Packaged i (March 23, 2022)
  • D-0734-2022 Class II — TESTOSTERONE CYPIONATE *GS* Oil 200 MG/ML Injectable, Packaged in a multi dose 1 (March 23, 2022)
  • D-0735-2022 Class II — TESTOSTERONE CYPIONATE *GS* (2 mL) 80 MG/ML Injectable, Packaged in a multi dos (March 23, 2022)
  • D-0728-2022 Class II — GONADORELIN (5ML) 0.2 MG/ML INJECTABLE, Packaged in a multi dose 10ML vial, Form (March 23, 2022)